FDA Clears First Drug for Rare Genetic Causes of Severe Obesity ...Middle East

Medscape - News
Setmelanotide (Imcivree) is indicated for weight management in adults and children as young as 6 years with severe obesity driven by genetic deficits in the melanocortin-4 receptor pathway. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Clears First Drug for Rare Genetic Causes of Severe Obesity )

Apple Storegoogle play

Also on site :



Latest News